Physician profile
John B Berry
NPI 1184602948
$1,067.60
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $275 · 2021: $123 · 2022: $264.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $227.18 | 2019 | |
| Medtronic, INC. | $197.92 | 2021-2022 | |
| Abbott Laboratories | $144.00 | 2020 | |
| Nevro Corp. | $117.12 | 2020 | |
| Shire North American Group INC | $89.84 | 2019 | |
| Stryker Corporation | $85.28 | 2021 | |
| Janssen Pharmaceuticals, INC | $50.79 | 2021-2022 | |
| Livanova USA, INC. | $29.16 | 2022 | |
| Intrinsic Therapeutics | $23.82 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.61 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $21.61 | 2019 | |
| Boston Scientific Corporation | $16.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.68 | 2019 | |
| Tanabe Pharma America, INC. | $13.81 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.